Rosetta Genomics Announces Issuance of Additional U.S. Patent (ROSG)

Rosetta Genomics ROSG today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,943,745, which is related to human hsa-miR-497 and its variants and covers the composition of matter. Human hsa-miR-497 is an important component of the Company's miRview mets and mets2 diagnostic tests for the accurate identification of the tissue of origin in Cancers of Unknown Primary and difficult to diagnose metastatic cancer cases. Rosetta Genomics recently announced the launch of an oncology sales team for these advanced microRNA-based diagnostic tests in the United States.